A detailed history of Vident Advisory, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 6,816 shares of NTRA stock, worth $1.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,816
Previous 1,910 256.86%
Holding current value
$1.14 Million
Previous $207 Million 318.35%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $479,561 - $636,161
4,906 Added 256.86%
6,816 $865 Million
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $126,896 - $167,548
-1,488 Reduced 43.79%
1,910 $207 Million
Q1 2024

May 14, 2024

SELL
$59.21 - $92.9 $9,355 - $14,678
-158 Reduced 4.44%
3,398 $311 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $133,527 - $222,747
3,556 New
3,556 $223 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.